CyberKnife® Radiosurgery for Non-functioning Pituitary Adenomas
Register now for the August webinar.
RADIOSA Trial and Beyond: Exploring the Full Potential of SBRT in Advanced Prostate Cancer
Register Now In this presentation, the presenters will discuss the design, outcomes, and clinical implications of the phase II RADIOSA trial, which evaluated stereotactic body radiotherapy (SBRT) alone versus SBRT combined with short-course androgen deprivation therapy (ADT) in patients with hormone-sensitive oligo-recurrent prostate cancer. The session will explore patient selection criteria, treatment strategies, progression-free survival […]
Local Ablation in the Management of Primary and Metastatic Gynecologic Cancers: A Review of Evidence and Indications for Stereotactic Body Radiotherapy (SBRT)
Join us for this informative review of the current evidence in SBRT for Gynecologic Cancers.
Moderate and Extreme Hypofractionation for Locally Advanced Non-Small Cell Lung Cancer
In this webinar, we will explore the available literature data reporting the outcomes of moderate hypofractionation and extreme hypofractionation applied in the setting of locally advanced non-small cell lung cancer.
CyberKnife® Radiosurgery for Skull Base Meningiomas: Integration, Simplification and Patient-Centered Approach
Don’t miss this webinar where Dr. Conti will delve into CyberKnife® Radiosurgery for skull base meningiomas. Discover how the CyberKnife System integrates seamlessly, simplifies procedures and enhances patient care.
SBRT for Non-Spine Bone Metastases
The upcoming webinar will provide a comprehensive review of the evidence for radiation treatment in non-spine bone metastases.
Radixact® System with Synchrony®: The Chiang Mai University Hospital Experience
Join the team at Chiang Mai University Hospital for this webinar who will share their experience of using Synchrony® with the Radixact® System.
Accuray Exchange Showcase: 2024 Conference Highlights
Missed the opportunity to watch the AEx Showcase live? Catch-up at your convenience: Day 1: CNS Indications Day 2: CNS Indications Day 3: Breast and Gynecological Cancers Day 4: Thorax and Rare Indications Day 5: Genitourinary and Gastrointestinal Cancers Watch the highlights now: Day 1 Day 2 Day 3 Day 4 Day 5 An […]
Use of the TomoTherapy® System for Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma (NPC) is endemic in southern China, including Hong Kong, Southeast Asia and North Africa…
Evidence, Outcomes and Practical Guidance to SABR in Primary Renal Cell Carcinoma for Your Clinic
Join us for this webinar to learn from Prof. Shankar Siva, an expert on SABR for primary renal cell carcinoma.
